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MICROVASCULAR OSCILLATIONS ELICITED LOCALLY BY COMBINED IONTOPHORESIS OF
PHENYLEPHRINE AND ACUPRESSURE. Frederick C. Lewis, Michael Scanned, Julie Park, and David
G. Silverman. Department of Anesthesiology, Yale University School of Medicine, New Haven, CT.
This study tested the hypothesis that organized vasomotion of the peripheral microvasculature
consistent with cholinergic oscillatory control could be elicited by local iontophoresis of phenylephrine and
that the response would be enhanced by acupressure at the Lung point of the ear (a method known to
increase vagal tone).
Heart rate, respiration, and forehead flow (via a 1mm2 laser Doppler surface probe) were
monitored in 8 healthy volunteers. Forehead flow was measured at three sites receiving iontophoresed
phenylephrine, iontophoresed normal saline (NS), or no iontophoresis (control site), respectively.
Volunteers received iontophoresis for an average of 30 seconds, followed by a ten-minute rest period, then
bilateral ear acupressure for two minutes.
The phenylephrine site showed a 25% reduction in flow following iontophoresis (p<0.01 using a
paired t test), while iontophoresis induced no significant change in flow at the NS or control sites. During
the period of ear acupressure, the phenylephrine site showed an increase in the amplitude and organization
of oscillatory activity as documented by an increase in intermediate-frequency (IF, 0.12-0.18 Hz) spectral
power when compared with the other two forehead sites and with the phenylephrine site at baseline (p<0.01
for all comparisons). This increase in forehead oscillatory power, which is consistent with parasympathetic
but not sympathetic oscillatory activity, was independent of respiration and of the major oscillatory power
of the ECG. No obvious or consistent change occurred in heart rate, standard deviation of heart rate, or
heart rate oscillatory power in the IF range, suggesting that there was no systemic effect from either the
phenylephrine or the acupressure.
These findings indicate that IF microvascular oscillations can be elicited by local iontophoresis of
phenylephrine in combination with enhancement of vagal tone by acupressure. The study provides a model
for investigating effects of acupuncture and may help advance the development of clinical monitoring of
autonomic function.
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Introduction

The existence of rhythmic variations in biological systems has been recognized for
centuries. Oscillations in cardiovascular variables such as heart rate and blood pressure have
been appreciated since at least 1733, when Stephen Hales noted beat-to-beat variations in these
variables while performing the first quantitative measurements of arterial blood pressure. Since
then, many others have described variability in heart rate and blood pressure (1,2). More
recently, quantification of these variations has been performed using computer techniques such as
power spectral analysis (3,4,5), with the most common of these techniques being Fourier analysis.
The fast Fourier transformation (FFT), a computer approximation of the original Fourier Series,
allows for the quantification of repeating signals in biological systems over a range of
frequencies.
Using the technique of FFT, investigators have identified several discrete frequency
bands which account for the majority of variability in heart rate and blood pressure. Lowfrequency (LF) fluctuations, below 0.12 Hz, are jointly mediated by the sympathetic and
parasympathetic nervous systems (5,6). High-frequency (HF) fluctuations, in the range of
0.12-0.30 Hz, are mediated solely by the parasympathetic nervous system, as evidenced by their
elimination with atropine but not by propranolol (6,7). Additionally, the sympathetic nervous
system is believed to be incapable of mediating fluctuations at frequencies higher than 0.12 Hz
because of the complex second-messenger system involved in adrenergic transmission (8).
A portion of the high frequency component of heart rate and blood pressure variability
has been ascribed to vagally mediated changes which occur at the heart in synchrony with
respiration. Inspiration produces negative intrathoracic pressure and decreased pulmonary
vascular resistance, which in turn lead to increased venous return to the heart and increased stroke
volume. The inspiratory decrease in thoracic pressure also leads to an acceleration of heart rate
due to a parasympathetic withdrawal triggered by baroreceptor unloading (9). High-frequency
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variability in blood pressure, rather than representing fluctuations in vagal efferent activity to the
smooth muscles of the vasculature, is thought to result from changes in stroke volume influenced
by the status of the respiratory cycle and its effect on venous return (10). Thus cycles of heart
rate acceleration and increased stroke volume occur with each inspiratory phase, setting them
equal to the respiratory frequency. Therefore, assuming a person is breathing at a rate of at least
12 breaths per minute, the high-frequency range of fluctuations can be further subdivided into
intermediate-frequency (IF, 0.12-0.18 Hz) and respiratory frequency (RF, 0.18-0.30 Hz) bands.
In addition to heart rate and blood pressure variability, rhythmic variation has also been
demonstrated in the diameters of small arteries, arterioles, and venules. Termed vasomotion, this
phenomenon was described by Nicoll and Webb based on their microscopic observation of bat
wings (31,12). Fagrell and colleagues later discovered this oscillatory activity in the
microvasculature of human skin by using video microscopy, positioning two small
videophotometric windows along a monitored capillary (13). In the early 1980s the technique of
laser Doppler flowmetry made possible the noninvasive continuous monitoring of microvascular
blood flow in skin (14,15,16). Laser Doppler flowmetry monitors flow in the 10-60 capillaries
500-700 nm below the skin surface by detecting frequency shifts of laser light as it is deflected by
moving red blood cells in the capillaries under a 1 -mm2 surface probe. The standard laser
Doppler output is red blood cell (RBC) flux, or the product of the number of moving RBCs in the
microcirculatory vessels under the probe (i.e., the number that cause a Doppler shift) and their
velocities (i.e., the magnitude of the shift). However, the vessels in which the flux is measured
are predominantly capillaries and postcapillary venules of the upper horizontal plexus which
exhibit little change in vessel diameter. Therefore, oscillations in laser Doppler flux are ascribed
to propagation of oscillatory activity in the smooth muscle of precapillary sphincters upstream of
the capillary bed (17).
Although the physiological role that vasomotion serves is uncertain, one of the most
compelling theories is that it may help to direct blood flow to certain body regions. Poiseuille’s

3

law states that the resistance of a vessel is inversely proportional to the fourth power of the
vessel’s diameter. Wilkin points out that “the resistance of a vessel with constant diameter is
notably greater than that of a vessel with the same average diameter in which the diameter
changes sinusoidally” (18). Thus oscillations, by creating over time a decreased vascular
resistance, may be a physiological mechanism for redirecting blood flow or even for
compensating for a state of relative ischemia.
By combining laser Doppler flowmetry with power spectral analysis, researchers have
quantified the frequencies of microvascular oscillations (10,19,20,21). Furthermore, investigators
have demonstrated that, similar to heart rate and blood pressure periodicity, different frequency
ranges of microvascular oscillations appear to correlate with varying degrees of sympathetic and
parasympathetic mediation.
The origin of microvascular oscillations is unknown and may be multifactorial. Nicoll
and Webb described vasomotion as the inherent property of vascular smooth muscle cells to
exhibit spontaneous contractions (11). Several researchers believe that this steady state of
“background” oscillatory activity can be altered by local metabolic demands (22,23,24). Siegel
proposed a biochemical explanation for the rhythmicity of vascular smooth muscle based on the
kinetics of the allosteric enzyme phosphofructokinase (25). Applying known enzyme kinetics
and tissue concentrations, he described a pathway through which changing substrate
concentrations could cause varying activity of the enzyme, leading to oscillations in glycolysis
and ultimately to oscillations in membrane potential and cell contractility. Wilkin demonstrated
that microvascular oscillations at 0.1 Hz are particularly prominent during the period of recovery
from postocclusive reactive hyperemia and aldehyde-induced hyperemia (18). Citing the
biochemical pathway described by Siegel as the source of the oscillations, Wilkin proposed that
the stimulus for oscillations in both cases is the physical or pharmacologic stretch of myogenic
cells. Following this stimulus, the oscillations become most prominent during the return from
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vasodilation (accompanied by hyperpolarization of smooth muscle cells) to resting sympathetic
vasoconstrictor tone.
Other theories on the source of microvascular oscillations account for autonomic
regulation of the microvasculature. LF oscillations (<0.12 Flz) are considered to be a marker of
sympathetic activity in heart rate and blood pressure. At the microvascular level, Bernardi and
colleagues demonstrated that skin blood flow oscillations at 0.1 Flz could be enhanced by
maneuvers (such as tilting) which increase sympathetic tone and blunted by pharmacologic
sympathectomy (20). As with heart rate and blood pressure, HF microvascular oscillations
(>0.12 Hz) are thought to represent purely parasympathetic influence because the sympathetic
nervous system’s second-messenger system makes it incapable of transmitting signals at these
higher frequencies (8). The respiratory frequency is known to account for a portion of the HF
range microvascular oscillations via mechanical transmission of variations in cardiac stroke
volume, in the same manner as discussed above for the respiratory influence on blood pressure
variability.
Using the squared coherence function, Bemardi et al. measured the correlation between
oscillations in skin blood flow of the finger and oscillations in blood pressure and heart rate (10).
The squared coherence function, a type of bivariate analysis, allows determination of whether two
signals oscillating at the same frequency maintain a stable phase relationship. They discovered
that HF oscillations in blood pressure and heart rate precede those in the skin blood flow,
indicating that these oscillations in the microvasculature reflect downstream transmission of
vagally mediated fluctuations in cardiac tone. By contrast, LF oscillations were found to
originate in the skin, as they preceded these same oscillations in blood pressure and heart rate.
Several additional observations are consistent with the theory of autonomic influence of
microvascular oscillations. Mevio and Bemardi compared skin blood flow oscillations in the
forearm and nasal mucosa using laser Doppler flowmetry (26). The nasal mucosa is known to
have rich autonomic innervation, both sympathetic and parasympathetic, whereas the innervation
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of forearm skin vessels, while mixed, is more sympathetic than parasympathetic. The
investigators found that increasing the respiratory frequency—and thereby the overall frequency
of any parasympathetic component—caused an increase in oscillatory frequency of blood flow in
the nasal mucosa but not in the forearm skin. They also discovered that the tilt test maneuver
(which is known to be a sympathetic stimulus) caused a significantly larger decrease in blood
flow oscillatory frequency in the nasal mucosa than in the forearm skin, suggesting that the
parasympathetic relative to sympathetic innervation is greater in the nasal mucosa vasculature
than in that of forearm skin. Furthermore, when Salerud and colleagues measured oscillatory
frequencies at multiple sites in one subject, they found frequencies in the forehead, upper arm,
forearm, and foot of 10.0, 7.2, 6.3, and 5.6 cycles per minute, respectively. The finding of higher
oscillatory frequencies proximally is consistent with the known higher ratio of parasympathetic to
sympathetic innervation at more central regions of the body.
In a further study of cutaneous laser Doppler flowmetry, Silverman and colleagues
measured the RBC flux at the volar forearm and the palmar surface of the finger at baseline and
after systemic infusion of phenylephrine (27). As expected, the laser Doppler flux decreased at
the finger site following phenylephrine administration. However, flux values in the forearm
increased during the infusion, suggesting a potential homeostatic response to increased plasma
concentrations of an oti-receptor agonist. While the vessels of both the finger and forearm are
known to be richly innervated with adrenoceptors, the forearm skin vessels are also under
cholinergic regulation (28,29,30,31). Additionally, the increase in flux seen in the forearm was
consistent with vagally mediated baroreceptor responses noted in other settings, such as carotid
sinus stretch and body tilting (32,33). Furthermore, the homeostatic nature of the vagal response
to infused phenylephrine was demonstrated by the finding that the pressure increase induced by
phenylephrine was markedly increased after vagal block with atropine (34). Thus it was
reasonable to hypothesize that the disparity between finger and forearm reaction to an dj-agonist
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was due to a cholinergically mediated homeostatic response in the microvasculature of the
forearm.
Based on the results of this study and the knowledge that cholinergic activity is primarily
responsible for oscillations in heart rate (heart rate variability), Silverman and colleagues next
hypothesized that cholinergic activity might induce oscillations in the microvasculature which
might be activated in the presence of a vasoconstrictive stimulus (35). To investigate this
hypothesis, they used laser Doppler flowmetry to measure flux in the forehead and the palmar
surface of the finger at baseline and after intravenous infusion of phenylephrine. In the forehead,
the average flux remained constant during the infusion and developed prominent oscillations in
the IF range (0.12-0.18 Hz). The cholinergic nature of these oscillations was confirmed by their
ablation upon intravenous administration of atropine. LF oscillatory power did not change during
any phase of the study. By contrast, finger flux decreased by 50% during phenylephrine infusion
and did not exhibit IF oscillations. The investigators concluded that the IF oscillations of the
forehead microvasculature were consistent with cholinergic oscillatory control.
Although these findings suggest a cholinergic parasympathetic control of the vasculature,
traditionally autonomic regulation of the peripheral vasculature is believed to be almost entirely
sympathetic. Aside from its role in “local functional hyperemia” (36) such as the erectile system
of the penis, acetylcholine (ACh) has been considered an “outcast as a vasomotor transmitter”
(36), and the parasympathetic nervous system is viewed as having “virtually no effect on
peripheral resistance” (37). This belief persists despite the identification of ACh receptors in
vessel walls (36,38), ACh-induced vasodilation upon iontophoretic delivery or continuous
infusion (39,40), and evidence of a parasympathetic vasodilator mechanism in the lower gingiva
of cats (41). Nevertheless, the traditional consensus as to the lack of physiologically relevant
cholinergically mediated vasomotion suggests that these IF oscillations do not originate in the
microvasculature, but rather represent the downstream transmission of oscillations in cardiac
stroke volume in response to a vagomimetic challenge and thus would be transmitted via pressure
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and flow waves to the periphery in a manner similar to the transmission of respiratory-induced
fluctuations in heart rate and blood pressure. Therefore, in order to suggest that these oscillations
represent a local parasympathetic control of the microvasculature, it is necessary to document a
lack of association between cholinergic oscillatory control at the heart and at the
microvasculature.
To demonstrate this lack of association, Silverman and colleagues measured laser
Doppler flux in the forehead and ventral forefinger of eight subjects first at baseline and then
during the infusion of phenylephrine to achieve a 50% decline in finger flux (42). Throughout
the study subjects breathed in time to a metronome at 12 breaths/minute (0.20 Hz) to fix the
frequency of respiratory oscillations. Although there was the anticipated baroreceptor-mediated
decline (10-15%) in heart rate with phenylephrine infusion, there was no significant change in the
magnitude of heart rate oscillations, which persisted at the respiratory frequency during both the
baseline and infusion phases. In contrast, the forehead flux developed increased oscillations
during the infusion phase, with a unique peak at approximately 0.14 Hz. Both the heart rate and
the forehead flux oscillations were eliminated by the infusion of atropine, confirming their
cholinergic nature. Additionally, continuous monitoring of blood pressure via a finger
plethysmographic technique in several subjects confirmed that the oscillations in forehead flux
occurred at a frequency distinct from that of systemic blood pressure. Furthermore, the
simultaneous use of multiple forehead laser Doppler probes revealed that the oscillations at
different forehead sites were not necessarily in phase with one another, indicating that the
oscillatory control was at the level of the microvasculature rather than at a central location which
would have coordinated the oscillations at the different sites. The peripheral mediation of the
phenylephrine-induced oscillations was further confirmed by their elimination by topical
application of a eutectic mixture of local anesthetic.
These observed cholinergically mediated oscillations during infusion of an oti-agonist are
consistent with reports of ACh-induced release of nitric oxide in response to changes in
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intraluminal pressure (43,44). Indeed, nitric oxide has been observed to “limit the work of
perfusion... by coordinating the behavior of resistance vessels” (45). In addition, the 5-10 second
half-life of nitric oxide is consistent with the period of the HF oscillations. A homeostatic
process such as the described cholinergic oscillatory control would help explain the observations
that subcutaneous injection of phenylephrine does not cause local blanching (46) and that
addition of vasoconstrictive drugs to an in vitro vessel preparation induces an endotheliumdependent compensatory vasodilatory response (47). Although there appears to be local control
of this oscillatory response based on the above study by Silverman and colleagues, it is unclear
whether the entire pathway mediating the oscillations is confined to the microvasculature or
whether there is a hierarchical control system similar to that of the smooth muscle of the
gastrointestinal tract, which is under both local and vagal control.
A microvascular homeostatic oscillatory mechanism may have special significance in
certain cardiovascular disease states. The addition of ACh to in vitro vessel preparations causes
vasodilation even in the context of vasoconstrictive drugs, but this ability to dilate is lost in the
presence of endothelial injury (47,48). Diabetic autonomic neuropathy and hypertension are both
associated with loss of autonomic activity and development of endothelial injury, and several
studies have examined changes in oscillatory behavior at both the central (i.e., heart rate and
blood pressure) and microvascular level in patients with these diseases.
In a study of hypertensive patients being tilted from supine to upright, the LF component
of heart rate fluctuations increased and the HF component decreased much less in hypertensive
subjects than in the control group, and the LF components of skin blood flow increased only in
control subjects (49). These findings suggest sympathetic and parasympathetic impairment in
hypertensive subjects.
Multiple studies have demonstrated impairment of sympathetic-range vasomotion in
diabetics. Stansberry and colleagues found the amplitude of very low-frequency vasomotion (1-2
cycles per minute) to be much lower in diabetic patients than in control subjects and that this
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decreased vasomotor amplitude also correlated with loss of function of thinly myelinated C-fibers
(50). Bemardi and colleagues found the power of 0.1 Hz microcirculatory fluctuations to be
significantly lower in diabetic than in control subjects (51). Aso and colleagues discovered that
the vasoconstrictor response (measured in the big toe) to deep inspiration (which is known to
elicit vasoconstrictive effects) was significantly decreased in diabetic patients compared with
healthy subjects (52). Furthermore, in diabetic patients the vasoconstrictor response was
negatively correlated with the duration of diabetes, the median motor and sensory nerve
conduction velocities, resting heart rate variability, and postural fall in systolic blood pressure.
Other studies have examined dysfunction in cholinergic and parasympathetic activity in
diabetics. Bemardi and colleagues found an absence of power in the HF band of the heart rate
variability power spectrum in diabetic patients (53). In addition, loss of HF oscillatory activity in
heart rate and blood pressure in diabetics was found to be associated with poor wound healing
(54). Morris and colleagues found the vasodilatory effects of both acetylcholine and sodium
nitroprusside (a nitric oxide donor) to be attenuated in diabetic patients compared with healthy
controls, suggesting that endothelial and/or smooth muscle function may be impaired in the skin
microcirculation of diabetic patients (55). Given the evidence that diabetic patients have both
impaired centrally mediated parasympathetic oscillations and attenuated cholinergically mediated
vasodilation, it is reasonable to suspect that they may also have a dysfunction of parasympathetic
frequency-range oscillations at the microvascular level.
If microvascular cholinergic oscillatory control serves a homeostatic function that is
impaired in patients with cardiovascular disease, it would be useful to have a method of testing
this function in patients at risk for developing these diseases before they show clinical signs of
impairment. In fact, there is mounting evidence that such autonomic impairment precedes
clinical signs. The diabetic patients found in Bemardi’s study to have decreased sympatheticrange microcirculatory fluctuations had no clinical symptoms of autonomic dysfunction (51); Aso
and colleagues’ study showing that diabetics had decreased vasomotor reflexes in response to
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deep inspiration was performed on diabetic patients without peripheral vascular disease or
evidence of autonomic dysfunction (52). These findings, coupled with evidence that sympathetic
nerve failure in diabetics occurs earlier than previously thought (56), suggest not only that
microvascular oscillatory dysfunction may contribute to the pathogenesis of these diseases, but
also that its early detection may help in the diagnosis and treatment of patients at risk for
cardiovascular disease.
As mentioned previously, it is unclear whether the entire pathway mediating IF
microvascular oscillations is confined to the vasculature or whether there may be a hierarchical
control involving more proximal regulation. To address this question, a method of eliciting the IF
microvascular oscillations previously seen on phenylephrine infusion was sought that could be
both performed and measured at a local level. Such a method would ideally be as noninvasive as
possible to avoid activating local pain pathways which could affect blood flow and interfere with
or prevent the oscillations. A review of the literature suggested that the least invasive means of
administering phenylephrine locally is via iontophoresis.
Iontophoresis is a technique which uses small, physiologically safe amounts of electric
current to administer soluble chemicals and drugs to a small surface region of the body such as
the finger, forearm, or forehead. By using an electrode of the same polarity as the charge of the
drug, the drug is driven into the skin by electrostatic repulsion in a quantity proportional to the
current applied. This technique avoids the pain and tissue disruption associated with needle
injection and the potential effects of systemic drug administration. Iontophoresis has found
widespread clinical applications in dermatology (57,58) and is also used in physical therapy,
primarily for the delivery of lidocaine and dexamethasone (60). The Department of Pediatrics at
our own institution regularly uses a commercially available iontophoresis system to deliver a
solution of lidocaine HC1 2% + epinephrine 1:100,000 prior to placement of intravenous catheters
(Iomed, Inc., Salt Lake City, Utah).
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Several investigators have already shown that a wide variety of drugs, including
norepinephrine, phenylephrine, acetylcholine, atropine, lidocaine, and nitroprusside have been
administered safely and effectively by iontophoresis (28,60,61,62,63,64). Indeed, phenylephrine
and norepinephrine administered iontophoretically induce local vasoconstriction (63), while
acetylcholine and nitroprusside cause the anticipated vasodilatation (62). However, these studies
measured changes in overall flow which were produced by iontophoresis of drugs, rather than
measuring changes in microvascular oscillatory patterns.
While awaiting the delivery of a suitable iontophoresis system, our research team tested
subcutaneous injection of phenylephrine as a potential local delivery method. Using a 24-gauge
needle, 0.1 ml of phenylephrine 1:25,000 was injected subcutaneously at a site on the forehead,
and 0.1 ml of normal saline was injected subcutaneously at a different forehead site. Preliminary
results indicated the occurrence of vasoconstriction and the development of IF oscillatory activity
at the phenylephrine site almost immediately after injection. However, the injection was found to
produce a wheal at the skin surface which may have caused local compression of blood flow and
may have altered the distance from the laser Doppler probe to the capillary bed in which flow was
being measured. Therefore, comparison of laser Doppler readings before and after injection may
have been unreliable. Additionally, the injection of drug was found by multiple subjects to be
painful. Thus there was the possibility of activation of a local pain reflex, with release of
histamine and other vasoactive elements which may have affected local blood flow.
If IF microvascular oscillations represent a homeostatic parasympathetically mediated
response, it is reasonable to hypothesize that maneuvers which increase vagal tone may increase
the power of these oscillations. One method which has been postulated to affect the
cardiovascular system via the autonomic nervous system is acupuncture. Investigators have
shown that acupuncture at different skin locations appears to activate sympathetic or
parasympathetic responses (or both) to different degrees (65). For example, investigators
examining the effects of manual acupuncture on LF and HF heart rate fluctuations found that
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acupuncture at the LI-4 (Hoku) point of the hand elicited both sympathetic and parasympathetic
responses, while comparable stimulation of the Lung point of the ear (inferior hemi-conchae)
caused a purely parasympathetic response (65). Therefore, use of an acupuncture technique to
stimulate the Lung point in a subject may have the potential to enhance the power of any
parasympathetically-mediated microvascular oscillatory activity that may be occurring.
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Purpose and Hypothesis

We believe that there exists a novel homeostatic mechanism in the cutaneous
microcirculation which is activated in response to a vasoconstrictive stimulus. To provide further
evidence of this mechanism, and to help characterize it with respect to the possible location or
locations of the stimulus for its activation, we hope to elicit high-frequency cutaneous
microvascular oscillatory activity in the forehead via the noninvasive local administration of
phenylephrine by iontophoresis. In so doing, we hope to replicate the effects seen in the forehead
following phenylephrine infusion by stimulating the response at a local level. Research has
already demonstrated that monitoring microvascular oscillatory activity provides information
about the presence and severity of sympathetic dysfunction, even before clinical signs develop,
particularly in the setting of diabetes (49,50,51). Having the ability also to monitor a
parasympathetically-mediated response would expand the value of monitoring cutaneous flow
periodicity by providing information on the status of both the sympathetic and parasympathetic
branches of the autonomic nervous system.
We hypothesize that the iontophoretic delivery of phenylephrine to the forehead skin will
induce changes in forehead microcirculatory flow similar to those induced by the systemic
administration of phenylephrine by Silverman and colleagues. Specifically, we anticipate that our
monitoring of laser Doppler flow in the forehead will reveal changes in spectral components of
variability indicative of intermediate-frequency (0.12-0.18 Hz) activation and that these changes
will be specific to the site at which phenylephrine is administered. We further hypothesize that
these changes will be enhanced by acupressure (a form of acupuncture) at the Lung point of the
ear.
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Methods

The local institutional review board approved the protocol for the present study; all
subjects gave their informed, written consent.
The study participants, all healthy nonsmoking males, were instructed to refrain from
caffeine and other vasoactive substances for several hours prior to each study session. At the
study’s start, the subject lay recumbent with arms, legs, and head maintained at heart level. The
room temperature was regulated at 71 ± 1°F. Surface electrodes were applied for monitoring
ECG and respiration. Two iontophoretic drug delivery pads (Iomed, Inc.) were prepared by
filling one with 1 ml of 1,600 mcg/ml phenylephrine and the other with 1 ml of 0.9% normal
saline (NS) diluted 1:6 in sterile water. One laser Doppler flowmetry probe (Periflux 2B,
Perimed, Sweden) was inserted through each of the two iontophoretic pads, which were then
affixed to different sites on the subject’s forehead so that the tips of the laser Doppler probes
rested against the skin, flush with the surfaces of the pads. A third laser Doppler probe was taped
to a third site on the forehead away from both iontophoresis pads. Thus laser Doppler probes
were affixed to three forehead sites: a phenylephrine delivery site, a normal saline delivery site,
and a control site (without an iontophoretic drug delivery pad). A current delivery device was
attached to each of the two iontophoretic pads, with the positive lead attaching to the drug
delivery pad and the negative lead connecting to a dispersive pad which was affixed to the
subject’s upper back.
During all study phases, the ECG, respiration, and laser Doppler flux were recorded at
250 Hz with a microprocessor-based system consisting of analog-to-digital converters,
commercially available data acquisition software (Snapmaster, HEM Data Corp), customized
software for beat detection and annotation, and commercially available systems for Fourier
analysis (Snapmaster, HEM Data Corp; Excel, Microsoft).
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Following the application of our monitoring devices, subjects were allowed to rest
comfortably for 5-10 minutes before being asked to breathe in synchrony with an audible
metronome at a rate of 12 breaths per minute (0.2 Hz). Metronome breathing was continued
throughout the remainder of the study except where otherwise noted. Baseline data were
collected for a period of 2 minutes. Both iontophoresis current delivery devices were then turned
on for a period of 10 to 30 seconds at a current of 2 mAmp. Following the period of
iontophoresis, the subject rested while the investigators monitored the laser Doppler flow patterns
for the appearance of oscillatory activity and/or a decrease in flow at the phenylephrine site
indicative of vasoconstriction. If no change in flow was detected at either site after 5 additional
minutes of recording, iontophoresis was repeated at both sites for an additional 10 to 30 seconds,
after which flow was again monitored for 5 minutes. This sequence was repeated as necessary
until a maximum total duration of iontophoresis of 2 minutes was reached.
When a >10% decrease in flow at the phenylephrine forehead site became evident, the
subject was allowed to rest for approximately 10 minutes. After this rest period, an investigator
applied manual fingertip acupressure to the Lung point (inferior hemi-conchae) of both of the
subject’s ears for a period of 2 minutes, after which the subject was allowed to rest for an
additional 2 minutes.

Analysis

The frequency and power of the laser Doppler flux signals were characterized by auto¬
power spectral density (APSD) frequency-domain analysis. The computer resampled the laser
Doppler flux signals at 5 Hz, a rate, according to Nyquisf s Theorem (66), more than sufficient to
enable identification of oscillatory frequencies within our range of interest (0.05-0.30 Hz). We
then selected multiple segments ranging from 2 to 3 minutes from each of the three laser Doppler
site tracings and from these generated sets of APSDphenyi, APSDns, and APSDcontroi in each subject
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using a traditional Parzan window, Gaa = [ave(SaS*a)]/df, wherein Gaa is instantaneous amplitude
spectral density of channel a, Sa is instantaneous amplitude spectrum of channel a, S*a is complex
conjugate of Sa, and df is frequency resolution (0.005 Hz). The laser Doppler flux time segments
selected for frequency domain analysis at each site were as follows: 1) baseline; 2) during
maximal vasoconstriction at the phenylephrine site; 3) during the period of maximum IF range
oscillatory power for each site (after iontophoresis but before ear acupressure); 4) during ear
acupressure; 5) immediately after ear acupressure. Thus the analyzed time segments represent
simultaneous recordings at all three laser Doppler sites with the exception of the “maximum IF
range oscillatory power” phase, which was selected as the period of maximum IF oscillations at
each site.
After the flux tracings from each forehead site and time segment had been characterized
by Fourier analysis, for each APSD the 0.01-Hz wide bin with maximum power (“maxbin”) in
the IF range was identified. The IF range maxbin power at all three sites was compared, for all
studies, using one-way analysis of variance (ANOVA). A paired t-test was then used to compare,
for all studies, the IF range maxbin power at the phenylephrine site versus that at the normal
saline site and at the phenylephrine site versus the control site.
In addition to comparing the maxbin power at the phenylephrine site with that of the
other sites, we compared the maxbin power during each time segment with the power at baseline
to quantify the overall change in maxbin power. Dividing the maxbin power at each segment by
the baseline power proved to be an unreliable technique because the baseline powers, while
generally negligible, varied enough (0.01-0.07 at the phenylephrine site) to cause excessive
distortion of such ratios. We therefore decided to quantify changes in maxbin power in the
following two ways. First, for each forehead site we calculated the maxbin power at each phase
minus the power at baseline. Additionally, we used a paired t-test to compare, for each forehead
site, the maxbin power during each time segment with the power at baseline.
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One study was selected for analysis of the beat-to-beat percent change in flux. Using
software for detection of R waves on the ECG tracing, the laser Doppler flux during each
heartbeat was recorded. The percent change in flux from one beat to the next was calculated
using the formula [((n2-ni)/ni)* 100] where ni represents the laser Doppler flux at one heartbeat
and n2 represents the flux at the subsequent beat.
In four of the studies, the time-domain indices of the heart rate and R-R interval (the time
in milliseconds between two consecutive R-waves as measured by an ECG) were reported as
mean ± standard deviation. For each time segment, the ECG tracing itself was also sampled at
250 Hz, resampled at 5 Hz, then characterized by APSD analysis. The IF range maxbin power of
the ECG tracing was recorded for each time segment.
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Results
The forehead site which received iontophoresed phenylephrine showed an average 25%
decrease in flux following iontophoresis. By contrast, after iontophoresis the NS site showed
either no change in flux or a mild increase, while flux at the control site did not change markedly.
The phenylephrine site showed an increase in IF range maxbin oscillatory power at
approximately 0.125 Hz during the phase of ear acupressure, which was significant compared
with the other forehead sites and with the phenylephrine site during the baseline period. No
consistent change was seen throughout the study in R-R interval, R-R variability, or IF maxbin
power of the heart rate.
Figure 1 shows a representative example of raw data collected during a study. The top
portion of the figure portrays the two-minute baseline period, while the bottom portion displays
the two-minute period during ear acupressure. Shown for each segment are the ECG tracing,
laser Doppler tracings for the forehead phenylephrine and control sites, and the respiratory
monitor tracing. The small rises and falls in flux represent downstream transmission of each
cardiac systolic contraction. In addition, periodic oscillations in flux can be seen most
prominently at the phenylephrine site during ear acupressure, where they show a frequency of
approximately seven per minute.
Figure 2 shows the mean laser Doppler flux measured at each of the three forehead sites
for each study during the five time periods of interest. Although the “maximum
vasoconstriction” phase, shown for all three sites, is based on the period of lowest flux at the
phenylephrine site alone, there were no obvious periods of increase or decrease in flux at the
other two forehead sites that are not reflected by the values plotted in Figure 2. Table 1 shows the
mean flux over all studies at each site during each time period. Also given in this table are p
values for a two-tail paired t-test comparing, for each site, the mean flux during each phase with
the mean flux at baseline. Because of the skewness of the data, the flux values were also
compared by a two-tail paired t-test after In (natural log) transformation, which helps correct for
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wide variability of a few single data points. These p values are also shown in Table 1. In
addition, because multiple t-tests were performed on the same set of data, Bonferroni’s method
was used to adjust the level of significance in order to reduce the probability of type I error (67).
p values indicating significance after Bonferroni’s adjustment are indicated in the table with an
asterisk.
As expected, there is a significant decrease in flux (approximately 25%) at the
phenylephrine site following iontophoresis (which occurred between the phases of baseline and
maximum vasoconstriction), indicating local vasoconstriction {p = 0.001-0.007). The
significance of this decrease in flux at the phenylephrine site is maintained after In
transformation. By contrast, no significant change in flux is seen at the control site, consistent
with there being no systemic effect of the phenylephrine. The variable increase in flux at the
normal saline site in several subjects indicates a potential hyperemic effect from iontophoresis
itself; this resulted in an overall increase in flux at the NS site during ear acupressure. Althoughp
values for the uncorrected data indicate a significant change in flux at the NS site during and after
ear acupressure when compared with baseline, no subject developed vasoconstriction at the NS
site immediately following iontophoresis.
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Mean Flux, Phenylephrine Site
- Study 1

-m--Study 2
Study 3
Study 4
-Study 5
-Study 6
—b--Study 7
-Study 8

Mean Flux, Normal Saline Site
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— Study 5
-•—Study 6
—I—Study 7
——Study 8

Mean Flux, Control Site
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Study 3
Study 4
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-Study 6
—I—-Study 7
-Study 8

Fig. 2: Mean laser Doppler flux for all studies.
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Table 1: Mean (standard error of mean) flux for all studies
Baseline
Maximum
vasoconstriction
oscillations
Phenylephrine

0.273 (0.033)

P
p (In trails)
Normal saline

0.243 (0.036)

P
p (In trans)
Control site
P
p (In trans)

0.230 (0.023)

Maximum
acupressure

0.204 (0.031)

0.207 (0.030)

0.001*
0.001*

0.001*
0.001*

0.281 (0.047)

0.280 (0.047)

0.11

0.11

0.13
0.237 (0.022)
0.24
0.29

Ear
acupressure

Post-

0.212(0.031)
0.007*
0.007*

0.206 (0.029)
0.005*
0.005*
0.243 (0.036)
0.038

0.14

0.291 (0.044)
0,026
0.07

0.237(0.021)
0.27
0.27

0.224 (0.027)
0.64
0.52

0.248 (0.022)
0.15
0.17

0.10

Data values indicate the mean flux for all eight studies at the given forehead site and time
period, p values are for two-tail paired t-test comparing the flux during each time period
versus the flux at baseline. The first p value in each set represents comparison of the
actual flux values between the given phase and baseline; the second p value represents
comparison after In transformation of the flux values for the given phase and baseline in
order to minimize the influence of skewness, p values retaining significance after
Bonferroni’s adjustment are indicated with an asterisk.
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Figure 3 shows APSDphenyi, APSDNs, and APSDcontroi during the baseline time period of
the study for which the raw data is shown in Figure 2. Also shown is the beat-to-beat percent
change in flux at all three laser Doppler sites during the baseline time period. Figures 4, 5, and 6
illustrate this same set of data during the following time periods: maximum vasoconstriction at
the phenylephrine site, ear acupressure, and immediately following ear acupressure, respectively.
As can be seen by comparing the figures, the APSD of the phenylephrine site develops a
prominent peak at 0.125 Hz during the phases of ear acupressure and post-acupressure, while the
other two sites do not develop as much oscillatory power in the IF range (0.12-0.18 Hz).
Examining the tracings of beat-to-beat percent change reveals an increased organization of the
beat-to-beat changes in flux at the phenylephrine site during and after acupressure compared with
the other forehead sites and with the phenylephrine site before acupressure.
Figure 7 plots the values of IF range maxbin power for each study. Reviewing the
graphs, a marked increase in IF maxbin power is noted in almost all subjects during the post¬
iontophoresis period, ear acupressure, or both. By contrast, with the exception of one subject at
the NS site, there is no obvious change in the IF maxbin power at either the NS or control site.
For each of the five study phases, the IF maxbin power was compared between all three sites
using ANOVA. Because of the appearance of several potentially outlying data points, the data
was corrected for skewness by taking the natural log (In) of each maxbin power. By ANOVA, a
significant difference exists between the maxbin powers at the three sites during the ear
acupressure and post-acupressure phases (p = 0.0009 and p = 0.036, respectively, for In
transformation corrected data).
Table 2 presents, for each forehead site and time segment, the mean maxbin power over
all studies. Included in this table arep values for a two-tail paired t-test comparing, for all
studies, the maxbin power at the phenylephrine site versus the NS site and at the phenylephrine
site versus the control site, p values for a paired t-test comparing the In transformation of the
maxbin power at the phenylephrine site versus the NS site and at the phenylephrine site versus the
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control site are also presented in the table. The p values in Table 2 indicate the development of a
significantly greater IF maxbin power at the phenylephrine site compared with the other two sites
during the phases of ear acupressure and post-acupressure (p < 0.05 versus both NS and control
sites during both of these time periods). A t-test comparing the In transformation of the maxbin
powers during the acupressure phase shows even greater significance than when comparing the
actual maxbin powers. Therefore, correcting for skewness in the data by using In transformation
increases the significance of the acupressure-phase IF oscillatory power at the phenylephrine site
compared with the NS and control sites.
Figure 8 plots, for each study, the maxbin power during each phase minus the maxbin
power during the baseline phase (phase-minus-baseline). Table 3 presents, for each forehead site
and time segment, the mean phase-minus-baseline value over all studies. Included in this table
are p values for a two-tail paired t-test comparing, for all studies, phase-minus-baseline at the
phenylephrine site versus the NS site and at the phenylephrine site versus the control site. These
p values indicate a significantly greater phase-minus-baseline power at the phenylephrine site
versus both the NS and control sites during the period of ear acupressure. Because several of the
phase-minus-baseline power values are negative (indicating a higher oscillatory power at baseline
than during a later phase), In transformation is not possible for this set of data.
Table 4 displays p values for a paired t-test comparing, over all studies, the IF maxbin
power during each phase with the IF maxbin power at baseline.
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Beat-to-Beat Percent Change in Flux at Baseline

Time (seconds)

Fig. 3: APSDphenyi, APSDns, APSDcontroi, and beat-to-beat percent change in flux during
baseline period.
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Beat-to-Beat Percent Change in Flux at Maximum Vasoconstriction

Time (seconds)

Fig. 4: APSDphenyi, APSDns, APSDcontroi, and beat-to-beat percent change in flux during
period of maximum vasoconstriction at the phenylephrine site.
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Beat-to-Beat Percent Change in Flux During Ear Acupressure

-Phenylephrine
—- — Normal Saline
.Control

Time (seconds)

Fig. 5: APSDphenyi, APSDns, APSDcontroi, and beat-to-beat percent change in flux during
ear acupressure.
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Beat-to-Beat Percent Change in Flux Post Ear Acupressure

Time (seconds)

Fig. 6: APSDphenyi, APSDns, APSDcontroi, and beat-to-beat percent change in flux during
post-acupressure period.
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Phenylephrine Site Maxbin Power, 0.12-0.18 Hz

Study 1
Study 2
Study 3
Study 4
Study 5
Study 6
Study 7
Study 8

Normal Saline Site Maxbin Power, 0.12-0.18 Hz

■Study 1
• Study 2
Study 3
Study 4
Study 5
-•—Study 6
H—Study 7
— Study 8

Control Site Maxbin Power, 0.12-0.18 Hz

Study 1
-a- Study 2
Study 3
Study 4
—*— Study 5
Study 6
—i— Study 7
Study 8

Fig. 7: IF range (0.12-0.18 Hz) maxbin power for all studies at phenylephrine, nonnal
saline, and control sites.
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Table 2: IF (0.12-0.18 Hz) maxbin power: mean (standard error of mean) for all studies
Baseline

Maximum
vasoconstriction

Maximum
oscillations

Ear
acupressure

Post¬
acupressure

Phenylephrine

0.024 (0.009)

0.061 (0.023)

0.070 (0.022)

0.100 (0.032)

0.140 (0.050)

Normal saline

0.016(0.008)
0.5
0.1

0.041 (0.019)
0.5
0.9

0.043 (0.019)
0.3
0.3

0.028 (0.015)
0.010*
0.005*

0.019(0.005)
0.043
0.033

0.026 (0.013)
0.9
0.6

0.030 (0.009)
0.3
0.8

0.037 (0.010)
0.2
0.4

0.008 (0.003)
0.025*
0.002*

0.020 (0.006)
0.046
0.056

P
p (In trans)
Control site
P
p (In trans)

Data values indicate the mean maxbin power for all eight studies at the given forehead
site and time period, p values are for two-tail paired t-test comparing normal saline site
vs. phenylephrine site and control site vs. phenylephrine site. The first p value in each set
represents comparison of the actual maxbin powers between the two sites; the second p
value represents comparison after In transformation of the maxbin powers for each site in
order to minimize the influence of skewness, p values retaining significance after
Bonferroni’s adjustment are indicated with an asterisk.
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Phenylephrine Site Maxbin Power, 0.12-0.18 Hz
(phase minus baseline)
Study 1
Study 2
Study 3
-X- Study 4
Study 5
Study 6
1
Maximum
vasoconstriction
minus baseline

Maximum
oscillations minus
baseline

Ear acupressure
minus baseline

Study 7
Study 8

Post-acupressure
minus baseline

Normal Saline Site Maxbin Power, 0.12-0.18 Hz
(phase minus baseline)
—♦—Study 1
—■— Study 2
Study 3
—X— Study 4
—*—Study 5
—•—Study 6
—S— Study 7
Maximum
vasoconstriction
minus baseline

Maximum
oscillations minus
baseline

Ear acupressure
minus baseline

Post-acupressure
minus baseline

-Study 8

Control Site Maxbin Power, 0.12-0.18 Hz
(phase minus baseline)
—♦—Study 1
—■— Study 2
Study 3
—X— Study 4
—Study 5
•

Study 6

—I—Study 7
-Study 8

minus baseline

baseline

Fig. 8: IF maxbin power, phase-minus-baseline. Data points represent IF maxbin
power at given phase minus IF maxbin power at baseline.
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Table 3: IF (0.12-0.18 Hz) maxbin power, phase minus baseline: mean (standard error of
mean) for all studies
Maximum
vasoconstriction

Maximum
oscillations

Ear
acupressure

Post¬
acupressure

Phenylephrine

0.037 (0.017)

0.046 (0.015)

0.076 (0.035)

0.116(0.051)

Norm saline

0.025 (0.022)
0.6

0.028 (0.022)
0.4

0.012 (0.019)
0.045

0.003 (0.009)
0.053

0.004 (0.010)
0.2

0.012 (0.010)
0.2

-0.017(0.011)
0.029

-0.005 (0.008)
0.053

P
Control site

P

Data values indicate the mean of (maxbin power at indicated phase minus maxbin power
at baseline) for all eight studies, p values are for two-tail paired t-test comparing normal
saline site vs. phenylephrine site and control site vs. phenylephrine site. No p value
retained significance after Bonferroni’s adjustment.
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Table 4: Paired t-test, IF maxbin power at each phase versus baseline
Maximum
vasoconstriction

Maximum
oscillations

Ear
acupressure

Post¬
acupressure

0.063
0.4

0.019
0.022

0.063
0.008*

0.058
0.040

P
p (In trans)

0.3
0.08

0.3
0.08

0.5
0.4

0.7
0.1

Control site
P
p (In trans)

0.7
0.3

0.3
0.043

0.2
0.4

0.5
0.3

Phenylephrine
P
p (In trans)
Norm saline

p values are for two-tail paired t-test comparing the IF maxbin power during each time
period versus the IF maxbin power at baseline. The first p value in each set represents
comparison of the actual maxbin powers between the given phase and baseline; the
second p value represents comparison after In transformation of the maxbin powers at
each phase in order to minimize the influence of skewness, p values retaining
significance after Bonferroni’s adjustment are indicated with an asterisk.
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Figure 9 plots the mean R-R interval over four time phases for four studies. The
“maximum oscillations at each site” phase is omitted from this plot because this phase was
different for each of the three forehead sites and therefore did not correlate with one specific ECG
time segment. Also shown in this figure is the standard deviation of the R-R interval in the same
four studies. Based on the R-R interval plot, there was no consistent change in R-R interval
during the course of each study. In particular, there is no obvious increase in R-R interval during
the ear acupressure phase, suggesting that there was no systemic vagal effect from acupressure.
There was also no consistent change in the variability of the R-R interval, as shown by the plot of
standard deviation.
Figure 10 displays the IF range maxbin power of the heart rate for four studies. The
“maximum oscillations at each site” phase is omitted from this plot for the same reason as in
Figure 9. Only one subject showed an obvious change in IF range maxbin heart rate power,
which occurred during the acupressure phase. This subject did not evidence an unusually high IF
power at the phenylephrine site, arguing against transmission of these oscillations from the heart.
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Mean R-R Interval for 4 Studies

-♦— Study 1
-■—Study 5
Study 6
Study 8

Fig. 9: Mean R-R interval and standard deviation of R-R interval for four studies.
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Fig. 10: IF maxbin heart rate power for four studies.
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Discussion

The results of this investigation include several interesting findings regarding
microvascular cholinergic oscillatory control. We have shown that iontophoretic administration
of phenylephrine, when accompanied by an acupressure method known to increase vagal tone,
precipitated an increase in the organization and amplitude of oscillatory activity in the forehead
microvasculature at a frequency believed to be incompatible with a sympathetic-mediated
oscillatory process (i.e., greater than 0.12 Hz). This frequency was also shown to be different
from the metronome-controlled respiratory frequency and from heart rate variability.
Furthermore, in this study these oscillations appeared in the setting of an average decrease in
local microvascular flux of 25% due to the phenylephrine. The present study offers at least three
major contributions to current investigations of microvascular cholinergic oscillatory control.
First, this study adds to the understanding of the physiology of microvascular oscillatory
activity. Prior studies by Silverman and colleagues demonstrated that systemic administration of
phenylephrine elicited forehead microvascular oscillations in the IF range (0.12-0.18 Hz) and that
these oscillations were distinct from the respiratory frequency and from heart rate variability
(35,42). However, although these studies separated the microvascular oscillations from known
systemic forms of periodicity, they did not address whether these oscillations could still be
mediated in part by baroreceptor activity, nor did they attempt to localize the components of the
reflex in terms of “afferent” or “efferent” limbs. Although the entire pathway (or pathways)
remains to be delineated, the current study provides evidence against a baroreceptor-mediated
mechanism.
There appear to be two basic components of the microvascular reflex seen in this study.
The first component is the vasoactive challenge (phenylephrine), as evidenced by the IF range
oscillations being significantly more powerful at the phenylephrine site than at the NS or control
sites during the ear acupressure phase. The second component is the acupressure, which we
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believe, in agreement with other investigators’ findings, led to an increase in vagal output (65).
With the introduction of ear acupressure, the phenylephrine and NS sites, which had previously
behaved similarly in response to their respective iontophoretic stimuli, suddenly showed
significant differences in their IF range maxbin oscillatory powers. Thus, we have shown that IF
range microvascular oscillations can be elicited at a local skin site by administering a
vasoconstrictive challenge specifically at that site and enhancing vagal output with acupressure.
Although this finding is a significant step forward from the prior investigation using systemic
phenylephrine, we cannot yet conclude that the entire oscillatory reflex is mediated locally. We
have demonstrated that the iontophoresed phenylephrine produced no systemic effects, as
evidenced by there being no change in flux at the control site and no consistent change in the R-R
interval or in R-R variability. However, given that acupressure was required to elicit the
oscillatory activity fully, we cannot yet rule out a central component to the pathway.
As its second major contribution, this study serves as a model which enhances our current
understanding of the mechanism of acupuncture. In this study acupressure (a form of
acupuncture) was required to elicit fully the local IF microvascular oscillatory effect. While this
finding initially came as a surprise to our team, it is consistent with the current knowledge of how
acupuncture works. Acupuncture is a much-studied but incompletely understood technique
which has been used for over 4,000 years to treat pain as well as a wide variety of medical
diseases ranging from asthma to gastrointestinal disorders to mood disorders (70,71). Based on
the traditional Chinese principle of opposites and the dynamic balance of the two opposing
forces, Yin and Yang, acupuncture has long been considered a technique which works by
restoring balance to a biological system whose homeostasis has been disturbed by a disease
process (70,72). A complete discussion of the many current biological theories of how
acupuncture may exert its effects is beyond the scope of this paper. However, common to many
of the theories is that acupuncture has little or no effect on normal function; rather, “only in
dysfunction does the ’balancing mechanism’ produce clear effects” (72). In light of this
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understanding, it seems reasonable to view the three laser Doppler forehead sites in terms of any
imbalances in blood flow which may have been imposed on them during the study. The control
site received no direct stimulation and, as expected, showed no significant change in its IF range
maxbin power throughout the study. The NS site underwent iontophoresis, which led to a
variable mild increase in flux in some subjects but did not result in a significant change in IF
maxbin power. The phenylephrine site, however, showed evidence of vasoconstriction based on
an average 25% decrease in flux following iontophoresis. It was at this site, where blood flow
homeostasis was most greatly disturbed, that the IF maxbin power increased significantly during
acupressure. In other words, we propose that the phenylephrine forehead site alone was primed,
by a vasoconstrictive challenge, to respond to the acupressure-induced increase in vagal tone
which mediated the homeostatic oscillatory response. Although the exact chemical nature of this
‘■‘priming” is unknown, one possibility is that the vasoconstriction leads to an increased local
concentration of acetylcholine, which is then present to exert its cholinergic homeostatic effect
with the increase in vagal tone.
This analysis suggests that in our study, phenylephrine-induced vasoconstriction created
the type of blood flow imbalance which microvascular oscillations may exist to offset. However,
several differences between these results and those seen in an earlier study involving systemic
administration of phenylephrine call for an explanation. The IF range forehead microvascular
oscillations Silverman and colleagues observed upon intravenous infusion of phenylephrine were
neither accompanied by nor preceded by any change in forehead flux (35). Additionally, the
oscillations were seen without any additional stimuli such as acupressure. These two major
differences between the studies, if considered together, may help to explain each other. Although
local tissue concentrations of phenylephrine were not measured in either study, the 25% decrease
in forehead flux in the present study suggests a higher local drug concentration at the forehead
phenylephrine site than may have existed when phenylephrine was administered systemically
with no change in forehead flux. If so, it is quite possible that the vasoconstriction induced by the
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iontophoresed phenylephrine was greater than the physiological imbalances that microvascular
oscillations may exist to offset. The compensatory system may initially have been overwhelmed
by the local phenylephrine concentration, and not until parasympathetic tone was increased by ear
acupressure was the homeostatic response able to exert a measurable effect. By contrast, with
systemic infusion of phenylephrine, the local forehead drug concentration may have created a
vasoactive challenge more similar to normal physiological imbalances, i.e., just enough to
activate the homeostatic oscillatory response, which in turn prevented a significant decrease in
local flow.
Another difference between the two studies lies in the route taken by phenylephrine to
reach the microvasculature. When infused intravenously, the phenylephrine began at the lumenal
aspect of the microvasculature and from there traveled to its effector site(s). However, the
iontophoresed phenylephrine passed through cutaneous and subcutaneous tissue, reaching the
outer component of the vessels first. Without a full knowledge of the receptors and effector sites
involved in the oscillatory pathway, we cannot yet describe how the system is affected by the
route of drug travel. Nevertheless, these differences between methods of administration should
be kept in mind during future studies, as they may help to explain any differences in the
oscillatory effect, particularly in the time course of the response.
The third major potential contribution of this study is toward the development of a
method of monitoring and testing cholinergic oscillatory control of the microvasculature in the
clinical setting. The interest in such a technique stems from multiple investigations which have
shown that autonomic dysfunction is responsible for considerable morbidity and mortality among
patients with cardiovascular diseases such as diabetes and hypertension (66,68). There has been
recent interest in the monitoring of microcirculatory oscillations as a method of detecting
autonomic dysfunction in patients before it becomes clinically apparent (50,51). In fact, several
investigators have not only demonstrated impairment of sympathetic-frequency microvascular
oscillations in diabetic patients, but also have shown that the degree of impairment correlates with
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the duration of diabetes, the resting heart rate variability, and the median motor and sensory nerve
conduction velocities (50,51,52). Adding to these tests of sympathetic dysfunction, the ability to
detect the presence or absence of a parasympathetic microvascular homeostatic response to
vasoconstriction would enable the testing of both divisions of the autonomic nervous system and
thereby increase the flexibility and sensitivity of such testing. The next critical step in the
development of this form of testing is to assess whether patients with advanced diabetes show
evidence of IF range microvascular oscillations in response to a vasoconstrictive challenge.
One major limitation of the present study is that the laser Doppler probe shows variability
in its absolute flux measurements at different forehead skin sites in the same subject. These
variations are presumably due to site-dependent differences in the microvascular anatomy
beneath the probe (69). We have attempted to overcome this problem in several ways. When
determining the significance of changes in flux measured by each probe, we compared the flux
during each phase with the flux at baseline so that changes would be detected at each site
regardless of differences between probes in the measurement of absolute flux. In addition, we
examined the beat-to-beat percent change in flux for each phase of interest rather than
considering only absolute flux. Finally, when evaluating maxbin oscillatory power (which is
affected by absolute flux), we examined changes in power over time and, for each forehead site,
compared the maxbin power at each phase with the power at baseline.
A second limitation of this study is that we have not yet confirmed the cholinergic nature
of the microvascular oscillations by administering atropine (as had been done with intravenous
phenylephrine). However, having now demonstrated the development of IF range microvascular
oscillations within minutes after iontophoresis, followed by their enhancement with acupressure
ten minutes after iontophoresis, we feel better prepared to administer atropine having some
knowledge of the time course of the oscillatory effect. Additionally, the observed oscillations
show a frequency that is outside the range within which the sympathetic nervous system is
believed to be capable of mediating, providing indirect evidence of their parasympathetic nature.
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Thus the present study has contributed to the understanding of the physiology of
microvascular oscillatory activity, to the theories regarding the mechanism of acupuncture, and to
the potential development of a clinical test for autonomic dysfunction. Further studies will
include the administration of atropine, which we hope will provide further evidence of a
parasympathetic mediation of the IF microvascular oscillations. Additionally, studies involving
patients with known advanced diabetes will reveal whether such patients have lost this
compensatory mechanism. The utility of a clinical test for both sympathetic and parasympathetic
dysfunction, as well as the potential for characterizing a previously unrecognized homeostatic
pathway, will motivate further research of this fascinating process.
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